Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Buchang Tianhao Pharmaceutical is a subsidiary of Shandong Buchang Pharmaceuticals, a leading Chinese pharmaceutical group specializing in the research, development, and manufacturing of cardiovascular and cerebrovascular treatments. The company focuses on integrating Traditional Chinese Medicine (TCM) with modern pharmaceutical technology to produce high-quality oral and injectable medications. Its product portfolio primarily addresses chronic conditions, including heart disease and stroke, as well as gynecological and orthopedic health. Buchang Tianhao operates large-scale manufacturing facilities in Zhejiang province that adhere to Good Manufacturing Practice (GMP) standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Buchang Tianhao Pharmaceutical.